Tacit Therapeutics
PrivateLast Round
Series A
Mar 9, 2026
Total Funding Raised
$29.5M
Company Overview
Tacit Therapeutics is a biotechnology company that develops RNA-targeted treatments to repair mutated genes using its proprietary Splicing-Directed Repair™ technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tacit Therapeutics Comparables
Compare Tacit Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ascidian Therapeutics | 88% | |
| Amber Bio | 84% | |
| Transit Therapeutics, Inc. | 84% | |
Tacit Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 9, 2026 | ||||
| Grant | Jan 15, 2024 | ||||
| Series A | Jun 8, 2022 |
Tacit Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mitsui Global Investment | Series A |
| Eisai Innovation | Series A |
| Michigan Capital Network | Series A |
| Civilization Ventures | Series A |
| KdT Ventures | Series A |
| National Science Foundation | Grant |
Tacit Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tacit Therapeutics's valuation, stock price, and market status.